1. Home
  2. ALMU vs RLMD Comparison

ALMU vs RLMD Comparison

Compare ALMU & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeluma Inc.

ALMU

Aeluma Inc.

HOLD

Current Price

$15.06

Market Cap

314.8M

Sector

Technology

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.35

Market Cap

307.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALMU
RLMD
Founded
2019
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
314.8M
307.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALMU
RLMD
Price
$15.06
$4.35
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$25.50
$10.00
AVG Volume (30 Days)
307.7K
990.2K
Earning Date
02-07-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,569,000.00
N/A
Revenue This Year
$20.69
N/A
Revenue Next Year
$68.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
307.21
N/A
52 Week Low
$5.69
$0.24
52 Week High
$25.88
$5.12

Technical Indicators

Market Signals
Indicator
ALMU
RLMD
Relative Strength Index (RSI) 47.58 58.47
Support Level $14.00 $3.98
Resistance Level $18.42 $4.79
Average True Range (ATR) 1.50 0.44
MACD -0.11 -0.06
Stochastic Oscillator 33.11 61.47

Price Performance

Historical Comparison
ALMU
RLMD

About ALMU Aeluma Inc.

Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: